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Abstract

A

novel transaortic ventricular cannula, known as the 'double barrel' cannula
(DBC), is designed to minimize the invasiveness of Ventricular Assist Device
(VAD) implantation by combining the inlet and outlet cannulae into a single

dual lumen cannula. Both the inlet and outlet lumen will pass through a single opening
in the apex of the left ventricle with the outflow then continuing past the aortic valve, into
the aortic arch. This design offers several potential advantages over the current stateof-the-art. The benefits of the DBC include less invasive surgery and providing
mechanical support to the septum. By routing the outflow through the aortic valve, the
need to access the external structure of the ascending aorta at the time of implantation
is eliminated thereby eliminating the need for open heart surgery.
In designing the DBC, close attention has been paid to the outflow portion of the

cannula since it was anticipated that this portion of the DBC could have the largest
impact on the device’s usability. The object of this study was to test the performance of
the valve with the cannula passing through it. Three different geometries of similar
cross-sectional area were compared. The geometries were circular, equilateral
triangular, and occluded leaflet. Experiments measuring aortic insufficiency (AI),
hemolysis, and differential pressure across the valve were conducted. Additionally,
high speed cinematography was used to analyze the dynamics of the valve’s sealing to
the cannulae.
All three geometries exhibited low and acceptable levels of AI (≤ 15% AI), with
the circular geometry causing the least amount of AI (7.1%) in comparison to the
control, an aortic valve with no cannula (2.4%). The hemolysis test results revealed that
all three of the cannulae designs generated negligible hemolysis (<0.5% after one hour)
as compared to the control case. The pressure loss across the aortic valve was found
to correspond to the area open to flow. Using the high speed cinematography, several
phenomena were observed during the sealing of the porcine valve; including leaflet
folding, leaflet bunching, and cannula displacement due to valve closure.
Aortic Valve Performance with Transaortic Ventricular Cannula
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1. Introduction

1.1

Ventricular Assist Devices

Ventricular Assist Devices (VAD) have been in clinical use since the 1980s and
have helped thousands of people suffering from heart disease and chronic heart failure.
They are implanted adjacent to the heart and supplement the heart’s natural pumping
(Figure 1). One of the drawbacks of implanting and removing a VAD is that the

Cannula

Figure 1 - Conventional VAD Implant

Adapted from (Heart Disease Health Center)
procedure involves a lengthy open-heart surgery that includes splitting and retracting
the rib cage in order to gain full access to the thoracic cavity. One way this could be
avoided is to implant the VAD through an incision in the abdomen (Shimpo, Akira and
Kazuya). This study aims to design and test a cannula to facilitate this novel, less
invasive surgical approach.
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1.2

The Double Barreled Cannula

Cannulae serve the function of delivering blood to the VAD and then back into
the circulatory system. In the case of the left ventricle (LV), the VAD attaches to the
apex of the LV for the inflow, and at the ascending aorta for the outflow of the VAD
(Figure 1) (Litwak, Koenig and Tsukui). The cannulae in this study are meant to
combine both the inflow and outflow cannulae into a single structure referred to as the
“double-barrel cannula” (DBC) (Figure 2). Both inlet and outlet lumen will pass through
a single opening in the apex of the LV with the outflow then continuing past the aortic
valve, into the aortic arch.

Figure 2 - Double Barrel Cannula

This design offers several potential advantages over the current state-of-the-art.
These include simpler surgery and providing mechanical support to the septum. By
routing the outflow through the aortic valve, the need to access the external structure of
the ascending aorta during implantation surgery is eliminated and therefore open heart
surgery is not necessary. This would facilitate an abdominal surgical approach for
implantation. Traditionally, to access the aorta through the abdomen, the cannula
attaches to the abdominal aorta. The main issue with this approach is that it can cause
2
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flow to regurgitate backwards across the aortic valve and into the heart leading to
insufficient flow to the upper extremities (Litwak, Koenig and Tsukui).
An additional benefit of the proposed design is the reduction of septal shift,
movement of the wall that separates the left and right ventricle, which is seen when the
VAD causes a negative pressure in the LV. This is only a benefit if the interventricular
septum is used as an anchor for the outflow extension of the DBC, in which case the
DBC would essentially act as a ventricular stent (Massey).

1.3

Cardiovascular Dynamics

The cardiac cycle (Figure 3) refers to the phases that make up a complete
heartbeat. Looking specifically at the left side of the heart, first we will follow the blood
path and then explore one complete cardiac cycle. Oxygenated blood from the lungs is
delivered to the left atrium via the pulmonary veins. From the left atrium blood is

Figure 3 - Cardiac Cycle

(Wellsphere)
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passed through the mitral valve into the left ventricle. The left ventricle is the main
driving chamber of the heart since from here blood is pumped to the rest of the body.
Blood in the left ventricle then passes through the aortic valve into the aortic arch and
on to the rest of the body.
The cardiac cycle consists of two major phases: diastole and systole. Diastole is
the portion of the cycle where blood is being pumped from the left atrium to the left
ventricle. The mitral valve is open to allow the flow into the ventricle and the aortic
valve is closed due to pressure in the aorta. Once the left ventricle is full, the mitral
valve closes, making the beginning of the systolic phase. The contraction of the left
ventricle causes the pressure in the ventricle to increase and eventually open the aortic
valve. The left ventricle ejects its blood volume into the aorta via the aortic valve. Once
the ventricle has fully contracted and begins to relax, the aortic valve will seal as a result
of the aortic pressure being higher than the ventricular pressure and the diastolic phase
will begin again.

1.4

Aortic Valve

The aortic valve is a one-way, pressure driven, tricuspid valve. There are three
leaflets, each cupped with the concave side facing the aorta, which enable the closing
and sealing of the valve when aortic pressure causes the blood to flow back toward the
ventricle (Geerts, Kerckhoffs and Bovendeerd) (Marieb and Hoehn). The valve is open
during the systolic phase of the cardiac cycle and allows blood to flow from the left
ventricle to the aorta. During diastole, the valve is sealed and prevents blood from
leaking from the aorta to the ventricle.

4
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The aortic valve contains three leaflets which are named for the coronary arteries
which originate behind them in the sinus of valsalva. They are the Right Coronary
Cusp, the Left Coronary Cusp, and the Non Coronary Cusp (Figure 4). The leaflets
come together along the sinotubular junction and meet at the commissures (Figure 5).
In the midpoint of each leaflet, there is a nodule and when the valve is closed these
nodules all meet in the center of the aortic valve. The shape of the valve and
positioning of the leaflets varies slightly from person to person. The porcine cardiac
tissue is an adequate substitute for human tissues (Crick, Sheppard and Ho) (Lim,
Chew and Chew). Due to the similarity and availability of the porcine tissues, a porcine
aortic valve was used in this study.

Figure 4 - Aortic Valve Anatomy

Dissected View. Adapted from (Netter)
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Figure 5 - Aortic Valve Anatomy Continued

1.5

Aortic Insufficiency

During diastole, there is a higher pressure in the aorta (~100 mmHg) than within
the ventricle (~10mmHg).. In a healthy functioning aortic valve, there iis
s no flow through
the aortic valve during diastole. In patients with heart disease, valve calcification, or a
disease of the aortic valve, flow may regurgitate into the ventricle from the aorta during
diastole (Figure 6).. This is referred to as Aortic Regurgita
Regurgitation
tion or Aortic Insufficiency
(AI). AI traditionally is defined as the volume regurgitated into the ventricle divided by
volume ejected from the ventricle,
ricle, and referred to as percent regurgitated (Bonow and
Nishimura).. For example, if the heart ejects 100 mL per contraction of the left ventricle
and 20 mL is leaked back into the ventricle during the diastolic phase, the patient
pa
would
have a 20% AI.
Clinically, AI is measured using an echocardiogram, which allows the doctors to
determine the volumes by examining jet velocities through the aorta. The three
geometries will be compared by this measure with the least percentage of aortic
insufficiency being beneficial.
6
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Figure 6 - Aortic Insufficiency

(CentraHealth)
It was predicted that the equilateral triangular cross section would exhibit the
least amount of aortic insufficiency. This is due to the fact that each leaflet has a flat
surface to seal against as opposed to the rounded surface of the circular cross section.
Although the Occluded Valve cross section also has a flat surface to seal against, the
flat edge lays adjacent to the leaflets .

1.6

Hemolysis

Hemoglobin is the chemical responsible for the blood’s ability to carry oxygen
throughout the body and remove carbon dioxide. In undamaged blood, hemoglobin is
only found within the red blood cells. If the red blood cell is ruptured or damaged, the
hemoglobin, along with other contents of the cell, is released into the plasma. It has
been shown that hemoglobin found in the plasma, known as plasma-free hemoglobin
(PfHb), is a good indicator of red blood cell rupture known as hemolysis. By binding the
hemoglobin with chemical reagents, the concentration of PfHb can be calculated by
measuring the amount of light the test samples absorb at specific wavelengths. The
concentration of PfHb can then be used to calculate the Normalized Index of Hemolysis
(NIH). The NIH is a metric used in hematology to draw similarities between tests done
in vitro and in vivo.
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Since the DBC passes through the aortic valve, it may interfere with the flow
through this valve and introduce unacceptably high shear stress to the blood flow.
Shear stress has been found to be a cause of hemolysis. The amount of hemolysis is a
function of both the turbulent shear stress and exposure time (Adrian) (Stien and
Sabbah) (Escudier and Smith) (Grigioni, Daniele and D'Avenio). Mechanical prosthetic
heart valves have been shown to cause hemolysis due to high shear stresses occurring
when the valve is closing between systole and diastole (Balducci, Grigioni and Querzoli)
(Krafczyk, Cerrolaza and Schulz) (Grigioni, Daniele and Del Gaudio). It is hypothesized
that the DBC could introduce hemolysis by causing high shear stresses when the valve
is closing. The hope is to find that the device will not contribute to blood damage and
that shear stresses experienced by the blood due to the DBC are acceptably low.

1.7

Motivation

1.7.1 Double Barrel Cannula Design
This study serves as a way to refine and develop the design of the DBC. By
determining the shape of the outflow section, the DBC can be constructed for use in
animal models. The purpose of these experiments was to find a cross sectional
geometry that enabled proper sealing between the aortic valve and the cannula. This is
important since the aortic valve holds back the pressure in the aorta. A poorly
functioning aortic valve decreases the cardiac output, requiring the ventricle to work
harder. By determining which geometry works best with the aortic valve, the design of
the DBC can be finalized and used in further testing.

1.7.2 Catheters
Several different surgical techniques, such as femoral catheterization, require
instrumentation to pass through the aortic valve. The results of this research are also
applicable to catheters used in mitral valve repair, coronary artery procedures, and stent
placement, to name a few. Currently, these tools cause a large increase in aortic
insufficiency and therefore decrease blood flow to the body (Massey). This reduced
flow is tolerable for a short period, but can cause problems during lengthy procedures.
8
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For a longer procedure the patient may be put on extracorporeal cardio pulmonary
bypass, a very invasive procedure with many risks. A better understanding of the effect
that an object placed in the aortic valve has on the valve’s function, the better these
surgical tools can be designed to limit their effect. This could lead to tools which enable
longer or more complex procedures to be done, using a less invasive method of
catheterization.

Aortic Valve Performance with Transaortic Ventricular Cannula
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2. Methods

2.1

Experiment Overview

In order to quantitatively measure the performance of the aortic valve with the
DBC’s outflow in place, the full cardiac cycle was mimicked with a physical bench top
model to analyze the valve. Natural aortic valves explanted from pig hearts were used
in this study. Three cross-sectional geometries of cannula were analyzed in a cyclic
pulsatile flow. The three geometries were compared to one another using the following
metrics: aortic insufficiency, pressure drop, valve dynamics, and hemolysis.
The experiment apparatus is a simple flow loop with a section made optically
clear to enable imaging of the aortic valve and cannulae with a high speed camera. The
experiment analyzed several geometries passing through an aortic valve in pulsatile
flow using two fluid mediums, phosphate buffered saline (PBS) and whole citrated
bovine blood. For the pulsatile flow, a pneumatic ventricle simulator was used to
generate a mean flow rate of 6.4 L/min and peak aortic valve pressure differential of 90
mmHg, both of which represent physiological flow. Flow rate and differential pressure
across the aortic valve were monitored during all testing.

2.2

Double Barrel Cannula

2.2.1 Cannulae Design
The cross-sectional geometry designs were inspired by the shape of the aortic
valve. The equilateral triangular variation utilizes the fact that the valve has periodic
symmetry and the cross section shares that same symmetry. It was hypothesized that
the equilateral triangular geometry would promote the valve’s ability to seal against the
obstruction since it provides a flat surface to seal against (Figure 7). The occluded
valve leaflet geometry was meant to take up the space normally occupied by one of the
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valve leaflets. Finally, the circular geometry represents the current design of catheters
which pass through the aortic valve.

Figure 7 - Cross Sectional Geometries Placed in Aortic Valve

Adapted from (Art)
The scale of these geometries was based on the size of the aortic valve, with
cross-sectional
sectional area held constant across the three geometries
geometries.. In the case of the
occluded valve leaflet, the scale wa
was solely based on the size of the aortic valves
valve used
in this study. The occluded valve leaflet occupies roughly one-third
third of the aortic valve’s
area and leaves the aortic valve with only two ffunctioning
unctioning leaflets. The other
geometries were designed to have the same
me area as the occluded valve leaflet,
leaflet using
the geometric equations for area of the respective shapes.
These experiments were conducted with solid cannulae cross-sections
sections passing
through the aorticc valve and not a hollow conduit. This is valid since the intended
purpose of this research was to design a cannula which passes through the aortic valve.
In use, the cross-sectional
sectional area will be a conduit for blood moving from the outlet
ou
of the
pump to the aorta

.

12

CEZO

2.2.2 Cannulae Placement
The cannulae were held in place using a threaded rod passing through a port in
the flow loop (noted ‘Cannula Holder’ in Figure 8). The rod was turned clockwise to
push the cannulae through the aortic valve and then adjusted to the correct angular
position. The original setup was designed to hold the cannulae in the center of the
aortic valve but due to the effects of gravity, this goal was not achieved in all tests.
Although the cannulae were not positioned in the center of the valve while at rest, the
valve would push the cannulae to center during the closing and subsequent sealing of
the valve. This phenomenon is discussed in section 4.2.1.

Figure 8 - Close up of Experimental Flow Loop Detailing Cannula Placement

The triangular geometry was tested in two positions, one (referred to as the
Equilateral Triangle) with the corners of the triangle aligned with the commissures of the
valve and another, (referred to as the Tri-Offset position), where the corners of the
triangle are aligned with the nodules of the valve leaflets.

2.2.3 Cannulae Fabrication
Of the three geometries, the occluded leaflet and equilateral triangular
geometries were molded for this study (Figure 9 and Figure 10). The circular geometry
was made from an undersized half-inch (0.485”) rubber cord o-ring stock.
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Figure 10 - Occluded Valve Leaflet Cannula

Figure 9 - Triangular Cannula

The mold was machined into two LDPE blocks. The mold consists of two mating
halves and four alignment holes. The channel used to make the equilateral triangular
cannulae was made using a 5/8” 60° chamfered end mill. The other channel was made
using a custom made 1” 120° chamfered end mill. On the opposite half of the mold, a
7/8” ball end mill was used to make a semicircular channel to align with the 120°
triangular channel. These two sides combine to create the occluded leaflet cannulae.
14
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The cannulae cross-sections were molded using RTV11 two part silicone
(Momentive, Albany, NY). The material was selected for its curing time (24 hours), work
time (1.5 hours), and elasticity (used to dampen vibration in electronics and comparable
to silicone rubber). The silicone was prepared by mixing 225 g of silicone with 1.125 g
of the curing agent for 2 minutes. The silicone mixture was then placed in a vacuum
chamber and degassed for 30 minutes under 25 mmHg of vacuum. The molds were
prepared by applying a spray-on PTFE mold release coating to both sides of the mold
(The Sherwin-Williams Company, Cleveland, OH). Guide pins were inserted on one
side of the mold and paper plugs were taped in place at one end of the mold channel.
This was to ensure that silicone did not leak out of the mold during the 48 hour cure.
The silicone mixture was then drawn into a 140 mL syringe and injected into the
channel of the mold while it lay horizontal on the table. The silicone was injected until it
was level with the top of the channel. The second side of the mold was then placed on
top and aligned using the guide pins. The mold was clamped using 3” C-Clamps and
placed upright, so that the channels were vertical. The silicone was allowed to settle
and a 12” brass rod was used to coax air bubbles to the surface. The mold was then
topped off using the syringe. An 8” section of 6-32 threaded steel rod with two nuts was
imbedded 4” into the top end of the mold. The rod was held in place using washers on
the top end of the mold. The threaded 6-32 rod was used to hold, position, and ensure
proper orientation of the cannulae in the flow loop. The mold was then allowed to cure
for 48 hours at room temperature.
To remove the finished cannulae, the guide pins were removed and the two
halves of the mold are separated. The cannulae were peeled from the mold and the
flashing and paper plug are removed with a razor. The molds are then cleaned and
ready to mold another set of cannulae.
The circular geometry was made using silicone rubber cord stock, which is
comparable to the RTV11 silicone. One end of the cord was drilled and tapped to
accommodate a 6-32 threaded rod. The threaded 6-32 rod was used to hold, position,
and ensure proper orientation of the cannulae in the flow loop.
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2.3

Experimental Rig Design

2.3.1 Flow Loop
A flow loop was constructed to mimic physiological flow conditions found in the
body (Figure 11). The loop was designed to produce an average flow rate of 6.4 L/min
and an aortic differential pressure of 90 mmHg. The flow loop used the Utah Artificial
Heart Institute’s Ventricle Simulator to drive the flow. National Instruments Labview
software and a USB DAQ were used to trigger the ventricular simulator and to record
the flow rate and differential pressure data.
The rest of the flow loop was constructed using Tygon tubing with PVC fittings
and valves. Since it is a low pressure system the tubing was sufficiently rigid to contain
the flow. A pressure transducer (not shown in Figure 11) was used to measure the
differential pressure across the aortic valve. An ultrasonic flow meter was connected to
the return side of the flow loop in order to measure the flow rate of the loop.

Figure 11 - Experimental Flow Loop Schematic
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2.3.2 Blood Flow Loop
The flow loop used for the whole blood hemolysis testing was altered to reduce
overall volume and the number of parts contacting the blood. The main modifications
were to reduce the size of the reservoir from 1.5 liter to 500 mL and to eliminate the
section of the flow loop which housed the glass viewing port.
Bovine blood was used for the hemolysis tests and was obtained from Joe’s
Meat Market in Ontario, NY. The blood was harvested from calves immediately after
slaughter according to standard practice for evaluation of cardiovascular devices
(Kitchen, Olson and Preston). The blood was mixed with a 3.2% sodium citrate
aqueous solution in a ratio of ten parts to one. Sodium citrate helps preserve the blood
and acts as an anticoagulant. The blood was stored at a temperature of 2-4° Celsius
until used in the flow loop. All blood was used within 72 hours of harvest.

2.3.3 Flow Visualization
Downstream from the valve, a glass ‘viewing port was constructed to enable
high-speed imaging of the valve. The ‘aorta’ and ‘ventricle’ section of the flow loop were
constructed of cast acrylic in order to facilitate the use of external lighting of the aortic
valve and cannulae. Additionally, high intensity white LED’s were inserted into the
‘ventricle’ side of the flow loop to backlight the valve and provide sufficient illumination
for the high speed cinematography.

2.3.4 Pneumatic Ventricle Simulator
The Pneumatic Ventricular Simulator (PVS) is a clear plastic mock ventricle constructed
to mimic the pulsatile contraction of the left ventricle (Figure 12). The PVS contains one
inlet with a two leaf mechanical ‘mitral’ valve and two outlets. The lower outlet, located
at the base of the ventricle, serves as the connection for the inlet cannula of a VAD. The
lower outlet was sealed off with a rubber stop cock for this study. The upper outlet
contains a two leaf mechanical ‘aortic’ valve which was mechanically fixed in the open
position by placing a piece of Tygon tubing in the valve to obstruct it. This was to allow
the natural porcine aortic valve to behave properly.
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The ventricle’s contraction (systole) and expansion (diastole) were controlled by
the Utah Artificial Heart Institute’s Ventricle Simulator. The Simulator switched between
a pressure line and vacuum line to contract and expand the ventricle. The positive
pressure was provided by a shop compressor and regulated to 350 mmHg. The
vacuum was provided by a Fischer LAV-3 vacuum pump providing 25 mmHg of
vacuum. The pressures were switched using a fast acting solenoid valve run via the
analog output on the National Instruments USB DAQ 6008 controlled by National
Instruments Labview software. The user interface and block diagram can be seen in
Appendix C: Labview User Interfaces and Block Diagrams.

Figure 12 - Mock Ventricle used with Pneumatic Ventricle Simulator

The software created a low frequency square wave (1 Hz) with variable duty
cycle to control the Driver. The tests were all run at 60 beats per minute (1 Hz) with the
systolic phase lasting for 40% of each cycle. These parameters resulted in the PVS
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providing 90 mmHg pressure differential across the aortic valve and a mean flow rate of
6.4 L/min. These adequately mimicked physiological values for pressure and flow.

2.3.5 Data Acquisition
The signals from the pressure and flow rate sensors were collected using
National Instruments USB DAQ 6008 along with National Instruments Labview software.
The differential pressure and flow rate data was collected at 100 samples per second
for a 10 second period. The data was written to a file and imported to Microsoft Excel
for post processing. The user interface and block diagram can be seen in Appendix C:
Labview User Interfaces and Block Diagrams.

2.3.6 Camera Triggering
High speed videos were taken using an IDT MotionPro X3 Plus High Speed
Digital Camera with IDT Motion Studio v 2.07.12 software. The camera was synced to
the flow loop using a five volt analog output trigger from the NI USB DAQ 6008. The
camera software was set to begin at the detection of the first rise in voltage output,
which corresponded to the first contraction of the ventricle. The camera then captured 2
seconds of footage at a rate of 60 frames per second, to ensure that two complete
cardiac cycles were present in each video sequence.

2.4

Valve Sourcing and Fixturing

2.4.1 Preliminary Valve Study
A sheep heart was obtained from a local butcher to conduct preliminary
observations and to determine the best methods for removing the aortic valve from the
heart and fixturing the aortic valve during experimentation. Following these preliminary
observations, it was determined that the best way to fixture the valves was to suture the
valve to a felt ring and then mechanically hold the felt in the flow loop. This method
enabled the valve to be held in a natural orientation, prevented flow from leaking around
the outside of the valve, and evenly distributed the holding force around the valve
(Figure 13).
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2.4.2 Valve Source
The aortic valves used during testing were taken from healthy adult pigs. The
porcine hearts were ordered from ASTCO, Incorporated, El Paso, TX. The hearts
arrived in a Styrofoam container filled with ice and were kept between 2-4° Celsius. The
valves had an approximate life of two weeks before the tissue degraded to the point
where it no longer functioned like a freshly explanted valve.

2.4.3 Valve Removal
In order to isolate and separate the aortic valve from the rest of the cardiac
tissue, a dissection was performed. A detailed procedure for removing the aortic valve
can be found in Appendix A: Aortic Valve Dissection. The aortic valve was carefully
removed from the heart and rinsed in 0.9% phosphate buffered saline (PBS). The
coronary arteries, which attach to the sinus of valsalva, were sutured shut in order to
prevent fluid from leaking around the aortic valve (Marieb and Hoehn). This does not
affect the function of the aortic valve since the flow to the coronaries is insignificant
compared to the mean flow through the aortic valve.

2.4.4 Valve Fixturing
The aortic valve was then sutured to felt rings. Felt was used to fix the valves in
the flow since it is easily penetrated with sutures, slightly deformable to the aortic tissue,
resistant to tearing, and mechanically strong enough to hold the valve in the flow. The
sutures used were Ti-Cron coated, braided, polyester, non-absorbable sutures with a
size 0 general surgery half circle tapered needle (Esutures, Mokena, IL). Using the
sutures, the one inch internal diameter by two inch outer diameter by quarter inch thick
felt washers were sutured to the valve using simple running stitches (Bell and Bell). The
stitches were tied off and glued to the felt ring with Loctite 404 cyanoacrylic adhesive to
ensure that the sutures would not slip.
The ventricle side felt ring was sutured to the aortic valve annulus. The aorta
side felt ring was sutured to the sinotubular junction (Figure 13) and the coronary
arteries sutured shut. To maintain the original length of the aortic valve, a 1.5 inch
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diameter PVC pipe spacer was cut to length and inserted between the felt rings.
Finally, to provide a surface to seal the aortic valve in the flow loop, a 2 inch diameter
PVC pipe spacer was cut to length and completely covers the OD of the aortic valve/felt
ring assembly for the entire length. The aortic valve assembly was stored in PBS until it
was needed for testing.

Figure 13 - Aortic Valve Assembly

2.4.5 Valve Preservation
In order to prolong the life of the aortic valve, the valve was preserved in a
solution consisting of 0.9% Phosphate Buffered Saline and 0.2% Gluteraldehyde.
Additionally, the valves were stored at 2-4° Celsius which kept the valve useable for up
to fourteen days.
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2.5

Measurements – Specific Methods

2.5.1 Spectrophotometer
The Genesys 10uv Spectrophotometer uses a single beam of visible light and a
photo detector to determine the absorbance of a sample. A single wavelength beam is
created by taking a collimated white light source and reflecting it off a diffraction grating
in order to separate the light into its respective wavelengths, much like a prism. Then
the separated light passes through an aperture that isolates a specific wavelength. The
light then passes through the sample and the remaining light is detected by a photo
detector. The photo detector translates the light into an electrical current via the
photoelectric effect. This current is then used to determine the amount of light absorbed
by the sample.

2.5.2 Plasma-free Hemoglobin Concentration
The concentration of PfHb was measured using the Cyanmethemoglobin method
(Malinauskas). The process involves mixing the separated plasma from the blood
sample with a chemical reagent which binds to all hemoglobin present in the sample.
The resulting compound is cyanmethemoglobin which absorbs at specific wavelengths
of light. Using a Spectrophotometer, the samples were measured for their absorbance
at a wavelength of 540 nm (Amatuzio, Grande and Wada) (Balasubramaniam and
Malathi).
In order to separate the plasma from the whole blood sample, the blood was
spun in a centrifuge for 10 minutes at 3,500 RPM’s. The plasma was drawn off the top
with a pipette, and spun a second time at 15 minutes at 10,000 RPM’s. This ensures
that all red and white blood cells are removed from the plasma.
The chemical reagent used for the Cyanmethemoglobin method is called
Drabkin’s Reagent (Table 1). The two cyanide compounds react with the hemoglobin to
produce cyanmethemoglobin.
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Compound

Quantity

Potassium Ferricyanide

400 mg

Potassium Dihydrogen Phosphate

280 mg

Potassium Cyanide

100 mg

Nonidet

1 mL

Distilled Water

1L

Table 1 - Drabkin's Reagent Formula

2.5.3 Hemolysis
Following the aortic insufficiency test, a hemolysis study was conducted on the
circular and equilateral triangular cross sections, both of which demonstrated very low
levels of aortic insufficiency. A test was run with the ventricular simulator in a simple
flow loop in order to obtain a baseline measurement of the hemolysis caused by the
pump.
A whole blood experiment, the most direct method for determining the cannula’s
effect on blood, was performed to test the DBC’s induced hemolysis. The experimental
set up was run with whole blood as the working fluid and the obstruction in place. The
outflow cannula’s induced hemolysis was measured by comparing these results to the
baseline tests. Hemolysis was measured using the Cyanmethemoglobin method.
The induced hemolysis rates are then used to calculate the Normalized Index of
Hemolysis (NIH). The NIH is a metric used in hematology research to equate in vitro
and in vivo blood testing. NIH is measured in grams per 100 liters and the calculation is
shown in Equation 1, where ∆

overall volume of the flow loop,

is the increase in plasma free hemoglobin, V is the

 is the percent hematocrit of the whole blood, Q is

the volumetric flow rate, and t is time in which the test was performed.
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Equation 1 - Normalized Index of Hemolysis
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2.5.4 Differential Pressure
The differential pressure was compared between the three geometries and the
control case. The peak systolic differential pressure was averaged over ten cardiac
cycles for each geometry and compared with the hydraulic diameter and the area open
to flow. Also, the peak systolic differential pressure was used to determine the pressure
loss coefficient across the aortic valve. The hydraulic diameter (DH) was calculated for
the aortic valve with each cannula in place using Equation 2 and Figure 14.
Equation 2 - Hydraulic Diameter
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Figure 14 - Definition of Hydraulic Diameter Variables

Adapted from (Art)
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The area and perimeters of the cannulae were calculated using their respective
equations (Fox, McDonald and Pritchard). The pressure loss coefficient (k) was
calculated using the relationships in Equation 3 (Fox, McDonald and Pritchard).
Equation 3 - Pressure Loss Coefficient

<
<
<
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Additionally, the pressure taps were used to prove that the flow loop mimicked
physiological flow through the aortic valves used in this study. The taps were passed
through the felt rings of the aortic valve assembly and opened at the edge of the tissue
on the inside of the aortic valve. This allowed the direct differential pressure across the
valve to be measured during all experiments. The pressure taps were constructed of
316 stainless steel 16 Gauge hypodermic tubing and were connected to a Validyne
DP15 variable reluctance pressure transducer via 1/16” ID Tygon tubing. The
transducer was run using a Validyne CD15 Carrier Demodulator which was calibrated to
18.98 mmHg/V.

2.5.5 Flow Rate
The Ultrasonic Flow meters use the Doppler Effect to determine fluid speed noninvasively. By knowing the cross-sectional area of the tubing in which the sensor is
attached, the volumetric flow rate can be determined.
Flow rates were measured using an em-Tec Ultrasonic clamp-on flow meter.
The flow meter was mounted to the reservoir return tube located between the aorta side
of the aortic valve and the reservoir. The flow meter was calibrated for use with 1/2” by
3/32” wall thickness Tygon tubing. The Ultrasonic flow meter was run using the em-Tec
DigiFlow controller and had an output of 0.25 V/(L/min).

2.5.6 Aortic Insufficiency
For this study, the AI was compared for the three cross-sectional geometries and
the control experiment over ten cardiac cycles. Five different diastole experiments were
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performed in order to test three basic geometries, the Equilateral Triangular geometry in
an offset orientation, and a no obstruction case. An aortic valve with no obstruction was
tested as a control and the results were used as a baseline reading for aortic
insufficiency. It was predicted that a healthy valve would exhibit 0% AI (Bonow and
Nishimura). After the baseline test, the three cross sectional geometries were fed
through the aortic valve and AI analyzed. The AI was also compared with the resulting
hydraulic diameter of the aortic valve with the cannulae passing through it.
AI is the ratio of the volume regurgitated during diastole to the volume ejected
during systole and was measured in this study by integrating the flow rate data over
time (Equation 4). Therefore the flow rate data was integrated using the trapezoidal
method over the systolic and diastolic portions of the cardiac cycle to obtain the
respective volumes (V).
Equation 4 - Aortic Insufficiency Definition

 =

=6>?7>8:@:6A
BC6D:6A

2.5.7 High Speed Cinematography
Another notable feature of diastole that was examined was the dynamics of the
valve closing and consequently sealing against an obstruction. The high speed
cinematography was used to witness which features of the valve and obstruction
geometry are important for mating and sealing. The dynamics of the valve sealing were
examined using high speed cinematography.
This is a qualitative measurement rather than quantitative since it was not initially
clear which aspects were important in sealing. Some aspects considered are the time
to seal, leaflet overlap, and leaflet collapse. To perform the dynamic observations, high
speed camera equipment was mounted to view the valve from a downstream position,
looking at both the cannula and valve from the aorta side of the flow loop.
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2.6

Measurement Calibration

2.6.1 Spectrophotometer
The spectrophotometer was calibrated to ensure the machine was functioning
properly. The machine was set to measure absorbance at 540 nm. In order to set the
zero absorbance of the spectrophotometer, 2 mL of Drabkin’s reagent were mixed with
1 mL of distilled water. This mixture was pipetted into a cuvette and placed in the
spectrophotometer. The corresponding absorbance was set as the blank absorbance
(absorbance read 0.000 A). A detailed setup procedure for the spectrophotometer can
be found in Appendix B: Spectrophotometer Setup.

2.6.2 Plasma Free Hemoglobin
In order to determine the percentage of PfHb in the blood samples taken during
the hemolysis testing, the total hemoglobin present in the whole citrate bovine blood
was first determined.
Table 2 details the mixtures used to calibrate the absorbance of a sample to the
percentage of Hemoglobin present in the sample.

Percent Total Hemoglobin Preparations
Hemoglobin Percentage

0.0%

2.5%

5.0%

7.5%

10.0%

15.0%

Whole Blood Sample (μL)

0

25

50

75

100

150

Distilled Water (μL)

1000

975

950

925

900

850

Table 2 - Hemoglobin Control Preparations

These preparations were then mixed with 2 mL of Drabkin’s reagent in plastic
cuvettes. Five replicates of each concentration were prepared. These were then
analyzed in the spectrophotometer. The results can be seen in Figure 16, except for
the valves pertaining to the 15% Hemoglobin samples, as they were out of the
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absorbance range for the spectrophotometer. The spectrophotometer output was ‘>3
Out of photometric range’ for all five readings and are therefore not included in the
graph.
In order to correlate the percent total hemoglobin to a concentration of
hemoglobin, the absorbance of different hemoglobin concentrations was determined.
This was accomplished by taking Powdered Bovine Hemoglobin and creating several
solutions of differing concentrations. One milliliter of these concentrations was then
mixed with 2 mL of Drabkin’s Reagent in plastic cuvettes. The different samples were
then measured for absorbance in the Spectrophotometer. The results are displayed in
Figure 15, where the relationship between absorbance of the mixtures and hemoglobin
concentration is a linear relationship with a slope of 3.56 Absorbance per g/dL.
Using the relationship between absorbance and hemoglobin concentration, the
total hemoglobin concentration of the citrated bovine blood can be determined. Since
the same batch of citrated bovine blood was used for the duration of all hemolysis
testing, the total hemoglobin concentration for all tests was 20 g/dL, which is within
normal natural values for bovine blood.

28

CEZO

Percent Hemolysis Absorbance Calibration
3

Absorbance

2.5
2

y = 24.514x + 0.0253
R² = 0.9978

1.5
1
0.5
0
0.0%

2.5%

5.0%

7.5%

10.0%

12.5%

Percent of Total Hemoglobin in Whole Citrated Bovine Blood

Figure 16 - Hemolysis Percentage Calibration

Absorbance of Hemoglobin
3

Absorbance

2.5

y = 3.5566x + 0.0216
R² = 0.9994
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0
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0.6
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Hemoglobin Concentration (g/dL)

Figure 15 - Hemoglobin Concentration Calibration
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2.6.3 Pressure Transducer
The Validyne DP15 Variable Reluctance Differential Pressure Transducer
was calibrated using a variable height manometer made of 1/16” Tygon tubing and a
polycarbonate 125 mL reservoir. The resulting voltage output versus pressure can be
found in Figure 17, with a slope of 18.98 mmHg/V.

Static Pressure (mmHg)

Validyne DP15 Reluctance Pressure
Transducer Static Calibration
70
60
50
40
30
20
10
0

experimental
Linear Fit
y = 18.978x - 1.1148
R² = 1
0

1

2

3

4

Output Voltage
Figure 17 - Pressure Transducer Calibration

2.6.4 Ultrasonic Flow Meter
The em-Tec Ultrasonic Flow Meter was calibrated by running a pump and
reservoir in a closed loop. The flow meter was clamped on the outflow side of the loop.
The pump was run at a constant speed and the outflow collected in a graduated vessel
for a specific amount of time. Data from the flow meter was collected during this test
and averaged over the time of collection to determine the calibration of the flow meter in
V/(L/min). The resulting calibration was 0.25 V/(L/min), which is consistent with the
initial calibration of the instrument approximately one year prior to this calibration.
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2.7

Experiment Validation

2.7.1 Pressure
The flow loop was tested in order to determine if physiologically accurate
pressures were being produced by the PVS. The flow loop was run with saline as the
working fluid, an aortic valve in place, and no cannulae present in the flow. The
differential pressure between the ‘ventricle’ and ‘aorta’ sections of the flow loop was
measured to validate that physiological conditions had been met. The peak systolic and
diastolic pressures do correspond to physiological conditions, but there is a second
order under damped response to sudden changes in pressure. The second order
response is not seen physiologically, and therefore the flow loop was analyzed to
determine the source. Several features of the flow loop were suspected to cause the
response, with the most likely source being the pressure transducers themselves.

Experimental Response

Pressure (mmHg)

80
60
40
Experimental Response

20

Experimental Data
0
-20
0

0.2

0.4

0.6

0.8

1

1.2

Time (seconds)
Figure 18 - Experimental Underdamped Second Order Response

The pressure taps and transducer can be modeled as an RLC circuit and are
subject to the same governing equations (Aerts, Carbonaro and Van den
Braembussche, Chapter III - Pressure Measurments). An RLC circuit is an electrical
circuit consisting of a resistor (R), inductor (L), and capacitor (C) with a time dependant
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current (I(t)). The flow through the pressure taps and transducer can be modeled as an
RLC electrical circuit with the fluid inertia analogous to the inductance of the circuit, the
viscous losses through the pressure tap acting as resistance of the circuit, the change in
volume of the transducer behaving like capacitance, and the volumetric flow rate (Q)
being the equivalent to electrical current.
Equation 5 - RLC Circuit 2
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The derivations of these terms can be found in Appendix D: Pressure Transducer
Analysis. Looking at the graph of a second order system we can see that it is under
damped due to the sinusoidal response (Figure 19). For the purposes of this study, the
information which is important in this system is the settling time (ts). The settling time is
how long it takes an under damped system to reach a certain tolerance of its final value
and stay between those margins (Figure 19). The settling time of the second order
system is defined in Equation 6 and is a function of the natural frequency (ωn), the
damping coefficient (ζ), and the tolerance interval.
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Figure 19 - Settling Time of an Under Damped Second Order System

(Nise)

Equation 6 - Settling Time for an RLC circuit

U = 

ln$XK Y !YZ K2
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[N 
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Using the formula for settling time along with the fluid analogies for an RLC
circuit we can define ωn, ζ, and ts (Aerts, Carbonaro and Van den Braembussche,
Chapter III - Pressure Measurments)
Measurments).. Using a tolerance interval of five percent, the
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settling time for the pressure taps and transducer system is 0.47 seconds. The
experimental pressure transducer data from the flow loop (Figure 20), shows a similar
settling time (~0.4 seconds).
Equation 7 - Settling Time for Pressure Tap and Transducer

U  
U  

2L
ln$XK Y !YZ K2
R

<
ln$XK Y !YZ K2
16 a

Since the settling time of the pressure tap and transducer closely match the
settling time found experimentally, it is concluded that this is the source of the second
order response. This means that the pressure oscillations following sudden changes in
pressure is not present in the flow loop and is only an artifact of the measuring
technique. However, it is difficult to say for certain considering the many assumptions
made to analyze the pressure transducer system. One of the assumptions is that the
flow in the pressure taps and transducer is defined as a linear second order system. In
reality it is a non linear system since the resistance of the system is a function of the
fluid velocity. Additionally, the flow in the pressure tap is assumed to be laminar. The
RLC circuit model does not take into account the elasticity nor the movement of the
pressure tap. Finally, the time settling equation is defined for a step in pressure, but the
experimental pressure is not purely a step but rather a sudden rise or drop in pressure
over a very short amount of time in comparison to the settling time.
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2.7.2 Flow Rate
The flow loop was tested in order to determine if physiological flow rates were
being produced by the PVS. The flow loop was run with saline as the working fluid, an
aortic valve in place, and no cannulae present in the flow. The transient flow rate was
measured on the ‘aorta’ section of the flow loop. The output from the flow meter was
monitored for 10 cardiac cycles and averaged over that time. The flow rate or Cardiac
Output (CO) of the PVS was 6.4 L/min, which is an acceptable value for a patient with
an LVAD implanted.

Experimental Cyclic Flow
15

100

60
5

40
20

0

Pressure (mmHg)

Flowrate (L/min)

80
10

0

0
-5

-20
Flowrate

Differential Pressure

Figure 20 - Experimental Pressure and Flow rate

An aortic valve without cannulae was used to obtain this Pressure and Flow rate.

2.7.3 Aortic Insufficiency
The flow loop was validated for both the AI and hemolysis measurements. The
control for the AI measurement was to use the flow loop with an aortic valve and no
cannula. The resulting AI was 2.4% with a standard deviation of 0.00941 over 10
measurements in each of two trials (Figure 21). This amount of AI is insignificant and
virtually undetectable clinically. This validates that the valves used in this experiment
were functioning properly. Additionally, the pressure and flow rate curves for the flow
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loop are indeed within physiological parameters. This validates that the PVS functioned
properly and that the flow loop did not add additional dynamics to the flow.

Experimental Flow Rate
Flowrate (L/min)

15
10
5
0
-5
0

1

2

3

4

Time (seconds)
Figure 21 - Integrated Volume for Aortic Insufficiency Calculation

2.7.4 Hemolysis
In order to quantify the amount of hemolysis caused by the flow loop and PVS,
two control tests were performed. First, a simple loop
loop, with the PVS running
ning in a closed
loop to a reservoir was used to quantify the amount of damage caused by the PVS. It
was thought that the mechanical valves in the PVS could cause a significant amount of
hemolysis, since mechanical aortic valve prostheses have been shown to cause
hemolysis. The results of this test were that the hemolysis was around 0.45%
% after 60
minutess of testing. This low level of hemolysis made the PVS an adequate pump to use
for the remainder of blood testing.
The next hemolysis control was done w
with whole bovine blood as the working
fluid in a test loop with an aortic valve in place, but no cannulae. This test was meant to
show that the additional components in the flow loop and the porcine valve would
contribute an insignificant amount of hemoly
hemolysis.
sis. Unfortunately, the test was stopped
after 10 minutes with the final PfHb level at 0.53% of the total hemoglobin in the whole
blood. The test was stopped due to a leak in the flow loop. Although the cause of the
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leak was not definitively determined, there are a couple suspects. Upon draining the
loop, two large thrombi were discovered. One was found in the PVS and the other
attached to the felt downstream of the aortic valve. It is possible that the clot got
pushed through the aortic valve during diastole and obstructed blood from flowing
through the valve. This in turn increased the ventricular pressure to the point that blood
was able to leak out of the flow loop. Due to a limited supply of whole bovine blood for
the testing, this test could not be repeated, but based on the subsequent tests we can
infer that the amount of hemolysis contributed by the flow loop and aortic valve are
insignificant.
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3. Results

3.1

Aortic Insufficiency

The comparison of aortic insufficiency is found in Figure 22, which shows the
mean aortic insufficiency with standard deviation. The circular geometry exhibited the
least amount of aortic insufficiency, although all the geometries exhibited AI less than
30% and are therefore classified as Mild AI according to the AHA (Bonow and
Nishimura).

Geometry's Average AI with Standard Deviation

20%

Aortic Insufficiency

18%
16%
14%
12%
10%
8%
6%
4%
2%
0%
Control

Circular

Triangular

Tri-Offset

Occluded

Figure 22 - Aortic Insufficiency of tested geometries
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The circular geometry demonstrated the lowest AI of all geometries at 7.1% AI
and was the most consistent of all experiments with a standard deviation of 0.00434.
The Equilateral Triangular cross section had an AI of 12.7% with a standard deviation of
0.0255, which was the largest deviation of all the geometries experimented. The
Triangular Offset test had the largest average AI at 15.1% AI and a standard deviation
of 0.00854. Finally, the Occluded Valve Leaflet cross section caused an AI of 13.0%
and a standard deviation of 0.0135.

Hydraulic Diameter Analysis
16%
Aortic Insufficiency Percentage

14%
12%
10%
8%
6%
4%
2%
0%
0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

Hydraulic Diameter (in)

Figure 23 - Aortic Insufficiency versus Hydraulic Diameter
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0.8

0.9

The AI was also compared as a function of hydraulic diameter (Figure 23 and
Table 3). The data points include all the cannulae geometries and the control case.
The control exhibits the least amount of AI and has the largest DH.
Table 3 - Hydraulic Diameter and Area of Cannulae

Hydraulic Diameter (in)
2
Area Open to Flow (in )

3.2

Control
0.822
0.531

Circular
0.337
0.346

Triangular
0.253
0.380

Tri-Offset
0.253
0.380

Occluded
0.556
0.352

High Speed Cinematography

Through examining the video of the aortic valve closing, the dynamics of the
aortic valve were able to be determined. Several phenomena were noticed when the
cannulae were present in the valve that did not occur during the control experiment.
Following are sample film strips from the experiments. Due to the perspective of the
footage, the cannulae appear larger than they actually are.

Figure 24 - Diagram of Key Features.

A) Tubing viewed from downstream; B) Felt Ring; C) Aortic Wall; D) Aortic Valve Leaflet, either
closed or open depending on phase of cardiac cycle; E) Cannula Cross Section.
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Although the circular cross section does perform the best in terms of AI, there are
several phenomena noticed in the high speed video which show that the valve has
issues conforming to the circular geometry. There is excessive bunching and folding of
the valve which is discussed in section 4.2.2.
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Figure 25 - Aortic Valve Sealing
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Figure 26 - Aortic Valve Sealing Around Circular Cannula
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Figure 27 - Aortic Valve Sealing Around Equilateral Triangular Cannula
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Figure 28 - Aortic Valve Sealing Around Equilateral Triangular Cannula (Offset Position)
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Figure 29 - Aortic Valve Sealing Around Occluded Leaflet Cannula
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3.3

Hemolysis

Hemolysis was measured for the triangular and circular cross section, as well as
the control tests. The results indicate that negligible amounts of hemolysis occurred
during all four tests run using whole citrated blood.
Of the two control tests, the aortic valve control test experienced the largest
amount of hemolysis with 0.53% PfHb present in the blood after ten minutes of testing.
This test was stopped due to complications discussed in section 2.4.7. The Ventricular
Simulator control produced 0.46% PfHb after sixty minutes of testing.
The two cross sectional geometries tested exhibited low rates of hemolysis. Both
geometries produced 0.49% PfHb after sixty minutes of continuous running of the flow
loop.
Additonally, the NIH was calculated for each of the tests. The rate of PfHb and
the resulting NIH for each hemolysis test are listed in Table 4.
Table 4 - Normalized Index of Hemolysis Results

∆

/

NIH

Ventricular Simulator Control

9.20E-06

0.017

Triangular Cannula

4.69E-06

0.009

Circular Cannula

1.99E-06

0.004

Trial
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Hemolysis for several geometries
Percent Plasma Free Hemoglobin

0.60%
0.50%
0.40%
Ventricular Simulator Control

0.30%

Aortic Valve Control
Triangluar Cannula

0.20%

Circular Cannula
0.10%
0.00%
0

10

20

30

40

50

60

70

Time (minutes)
Figure 30- Hemolysis Test results for several geometries and control tests

3.4

Pressure

The peak systolic differential pressure across the aortic valve was measured for
each of the three geometries and the no cannula control case. The pressure data was
plotted against the hydraulic diameter (Figure 32) and the area open to flow (Figure 31).
Additionally, the pressure data, hydraulic diameter, and area open to flow were used to
calculate the coefficient of pressure loss across the aortic valve (Figure 34 and Figure
33).
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Differential Pressure at Peak Systole
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Figure 32 - Differential Pressure versus Hydraulic Diameter

Differential Pressure at Peak Systole
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Figure 31 - Differential Pressure versus area open to flow
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0.600

Pressure (mmHg)

k, Found by Hydraulic Diameter
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Figure 34 - Coefficient of Pressure Loss (Hydraulic Diameter)
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Figure 33 - Coefficient of Pressure Loss (Area open to flow)
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3.5

Error and Uncertainty Analysis

Error and uncertainty are inherent to any investigation where physical
measurements are taken. Although error and uncertainty are unavoidable, they can be
mitigated by design of the experiment or accounted for in the data analysis. Error can
be broken down into two types, random and bias. Uncertainty, in its many forms, can
be calculated and includes everything from human error and accuracy of measurement
instruments (Aerts).

3.5.1 Random Error
When measurements of the same item are repeated, the difference between
these measurements and the mean of the measurements is the random error. All the
measurements in this study are subject to random errors, but the effects of this error on
the results can be limited.
For instance, the measurement for AI uses two techniques to mitigate this type of
error. The AI measurement is calculated from the flow rate measurement over time. By
integrating the flow rate over a long period of time, the random errors due to the flow
rate measurement are eliminated. This is due to the fact that random error is both
positive and negative to the actual value. Therefore, by summing (or integrating) a
large number of measurements, the positive and negative random errors will cancel
each other. This is good for reducing random error from the sensor, but due to the
experimental setup, there is still random error associated in the actual flow rate itself. In
order to quantify this random error, AI was calculated for several cardiac cycles at the
same PVS parameters. The random error in this case is quantified by taking the
standard deviation of the duplicated measurements (Aerts).

3.5.2 Bias Error
Bias error occurs when there is a constant difference between the mean
measured value and the actual value. This type of error can be accounted for and the
data adjusted to reflect the actual value (Fox, McDonald and Pritchard).
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An example of bias error in this study is the data acquisition. The USB DAQ
used to collect the pressure and flow rate over time has a constant voltage bias. The
bias was measured and subtracted from all subsequent data to ensure that the
collected data points reflected the actual output of the sensors.

3.5.3 Uncertainty
The estimated variation of a measurement is known as uncertainty. Uncertainty
of a measurement is function of the precision of the measuring instrument and the
manner in which the instrument is operated. Uncertainty can also be determined for
calculated values.
The uncertainty of a measurement such as hemolysis, accounts for several
sources of uncertainty. The resulting hemolysis percentage versus absorbance found in
Figure 16 has variation due to the precision of the pipettes, the spectrophotometer, and
person using the equipment. The experimental data was fit to a curve using the leastsquares method (Equation 8) in Microsoft Office Excel 2007. The resulting linear fit of
the data was used to determine the percent hemolysis found in each sample during the
hemolysis testing. Therefore the variability or uncertainty of each point on the line
needed to be determined. In order to accurately determine the variability of each point
on the linear fit, the standard error of the least-squares was calculated using Equation 9
(Beckwith, Marangoni and Lienhard V).
Equation 8 - Sum of Squares
N

c = def8 − f(g8 )h<
<

8ij

Equation 9 – Standard Error of Least-Squares Fit
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Equation 10 - Uncertainty of Hemolysis Measurement
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From the standard error, the uncertainty can be calculated for each point using
Equation 10 (Beckwith, Marangoni and Lienhard V). The resulting quantity for the
standard error of the least-squares fit corresponds to ±0.25% hemolysis. Therefore, the
uncertainty at a measured value of 0.38% hemolysis, is ±67% of the hemolysis value.
This is the largest uncertainty of all the measured values since it corresponds to the
lowest measurement of hemolysis.
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4. Discussion

4.1

Aortic Insufficiency

The results from the AI measurement indicate that while the shapes do produce
a consistent and measureable amount of AI, it is well below AHA recommendations for
intervention. The AHA rates AI from 0-30% as mild, and only suggests using
medication or a change in diet if you are at the upper end of that scale. From 30-50%
AI the AHA classifies the AI as Moderate and recommends a regimen of medication and
a change in diet to control and lower the AI. With more than 50% AI, labeled as Severe
AI, the AHA recommends a valve replacement along with medication and diet change.
The method of intervention used is on a patient to patient basis and the AHA AI metrics
are merely a guideline for physicians (Bonow and Nishimura).
Even though the AI caused by the cannulae are low, they are not necessarily
indicative of the AI the cannulae would cause in vivo, especially with diseased valves or
hearts. The fact that aortic valves used were from healthy pigs means that the valves
were more pliable and they did not contain fused leaflets or calcification. The AI was
merely used as a metric for comparing the effectiveness of the cannulae cross sections.
Additionally, the effect of VAD support on AI was not considered in this study.
Although the flow rate through the aortic valve was similar to natural blood flow while on
VAD support, the pressures were compared to natural physiologic blood flow. The
pressure in the ventricle while on VAD support can become low enough to cause
suction on the ventricle side of the aortic valve. The effect that this suction has on the
AI was not determined in this study but could be analyzed in further bench top testing.
One item noticed is that even when the cannula sections are not perfectly
positioned, the cannula would move to center during diastole. This occurred for both
radial and angular displacements. Precisely positioning the cannulae during the
experiments was difficult due to gravity acting on the cannulae and the mechanism used
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to rotate the cannulae. Proper position at the start of the tests seemed to have a limited
effect on the aortic insufficiency with the exception of the Equilateral Triangular cross
section.
Triangular cross section aortic insufficiency standard deviation was rather large
compared to its mean value and to the standard deviation of the other tests. This can
be attributed to radial and angular displacement of the cannula.
The equilateral triangular cannula exhibited two stable positions, one with the
corners aligned to the aortic valve commissures, and the other with the corners aligned
with the leaflet nodules. The latter position was referred to as the triangular offset
position. The interesting finding in this position was that the valve would rotate and
push the cannulae to center even when the corners aligned with the nodules of the
leaflets. As expected, this resulted in a larger amount of AI because the leaflets had to
seal against a sharp corner. Although it is a more difficult geometry to seal to, the valve
was still able to adequately seal to the cannula, as indicated by the AI of 15.1%.

4.2

High Speed Cinematography

From analyzing the still images of the high speed cinematography, many things
can be concluded. The dynamics of the valve sealing against the cannula were
witnessed as well as several phenomena, such as movement of the cannula, leaflet
folding, and leaflet twisting. The valve behaved normally for the control tests and did
not exhibit any notable behavior.

4.2.1 Cannulae movement
As previously mentioned, the cannulae would get pushed to the center of the
valve during diastole even if the cross section was out of position during systole. This
movement would take place during the transitions between diastole and systole and
only occurred when the circular and triangular geometries were in the flow. This
resulted in a slightly longer period of time where the valve was in the act of closing since
the leaflets were centering the cannula. This effectively increased the length of the
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diastolic portion of the cardiac cycle and allowed a longer time during which
regurgitation could take place.
The circular geometry experienced a radial displacement, meaning that if the
cannula was resting against the outer edge of the aortic valve, the leaflets would push
the cannula to center during the closing of the valve. This movement can be seen in
Figure 35, where the cannula moves from left to right over the course of 166
milliseconds.
During the triangular geometry tests, both radial and angular displacements were
noticed when analyzing the high speed cinematography. This means that not only
would the valve move to center as it did with the circular geometry, but it would also
rotate it to a ‘preferred’ position. It is interesting to note that the valve would rotate the
cannulae to a ‘preferred’ position even if the original position was off by as much as 15°.

Figure 35 - Cannula Movement

Aortic Valve Performance with Transaortic Ventricular Cannula

57

The ‘preferred’ positions refer to the two orientations to which the aortic valve
would push the cannula repeatedly and consistently. The first position is when the
corners of the triangle align with the aortic valve commissures. The other stable
position occurred when the corners of the triangular cannula aligned with the leaflet
nodules and is referred to as the triangular offset position. This is a little counter
intuitive since it requires the leaflets to deform around a sharp (60°) corner.

4.2.2 Valve leaflet deformation
It was noticed that the valve leaflets themselves were prone to bunching and
folding due to the presence of the cannulae. This occurred when a cannula was
present in the valve, but varied in the severity and repeatability of the deformation.
Experiments with the circular cannula in place repeatedly demonstrated leaflet
deformation. The leaflet would fold and bunch in its effort to conform to the curved
surface of the cannula while closing against it. This phenomenon can be seen in the
still image (Figure 36) taken using high speed cinematography.

Figure 36 - Leaflet Bunching

Leaflet edge is highlighted for clarity
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While the cyclic folding and bunching of the leaflets did not cause any noticeable
defects during the short in vitro experiments, it could be a source of inflammation and
tissue degradation in future long term animal model testing. Since the leaflet
deformation varies between the geometries and is most pronounced in the circular
geometry, the long term effects caused by the leaflet deformation could also vary
between geometries.

4.2.3 Valve twisting
Another dynamic noticed from the porthole in the flow loop was valve twisting.
This occurred in a few experiments and was never recorded by the high speed
cinematography. It was observed during preliminary tests while trying to align the valve
and cannulae. Although this phenomenon was not present during the testing from
which the AI was calculated, it is still significant. The fact that the valve twists shows
that there is considerable force acting on the valve leaflets. Not only can the leaflets
push the cannulae into position but the valve itself can be moved.
The twisting of the valve was eliminated by tightening the aortic valve assembly
to the flow loop. While this proved adequate for in vivo use, the aortic valve may be
able to move more freely in the body. Since the aortic valve already moves with the rest
of the heart during each cardiac cycle, this valve twisting could alter valve dynamics.

4.3

Hemolysis

The hemolysis results are promising but inconclusive. Of the two geometries
tested, there is no distinguishable difference in the induced hemolysis. Additionally, the
total amount of hemolysis is at the lower end of what the designed test is capable of
measuring. This fact also attributes to the rather large uncertainty found for the
hemolysis measurements. Although the uncertainty ranges from ±50-67% of the
hemolysis value, the values are still low enough that the hemolysis rates are
insignificant. The hemolysis test could be redesigned in order to provide a more precise
analysis of hemolysis. The test used in this study was designed to determined
hemolysis rates between 0 and 10 percent of total hemolysis. If the test was
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redesigned to measure hemolysis between 0 and 1 percent hemolysis, the standard
error would be considerably lower in comparison to measured values.
The important thing to note about the hemolysis results is that the tests produced
negligible amounts of damage to the blood cells. This is important since it shows that
the valve will comply with the flow and not produce turbulent jets capable of red blood
cell damage, even when the leaflets of the valve are considerably obstructed compared
to their natural dynamics.

4.4

Pressure

The peak systolic differential pressure results show that the pressure drop is a
function of the area open to flow but not of the hydraulic diameter. This is interesting
since the hydraulic diameter is meant to quantify the effective diameter of non circular
geometries, by taking into account the wall effects on the pressure loss.
In order to further analyze the relationship between the peak systolic differential
pressure, area open to flow, and hydraulic diameter, the coefficient of the pressure loss
across the aortic valve was calculated using two methods. First k was determined by
using the hydraulic diameter and then plotted against the pressure loss. What is
interesting is that the resulting graph (Figure 34) demonstrates no functionality between
hydraulic diameter and pressure loss. Then k was calculated using the area open to
flow and plotted against the pressure loss. This time the resulting relationship between
the area and pressure loss is linear (Figure 33). This is interesting, although the
coefficient of pressure loss is technically supposed to be a constant value relating the
pressure loss, flow rate, and diameter.

4.5

Cannulae Comparison

From combining the results of the AI, video, and hemolysis tests, it seems that
the triangular cross section performed the best within the aortic valve. This assessment
is not necessarily conclusive, as there is evidence that the circular and occluded valve
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cross sections would also be suitable in vivo. Further testing of these designs could
better predict which would best work with the aortic valve.
The geometries were ranked on a scale of 1-3, where the lower the number
refers to a better performance. The ranks of each metric were tallied for each cannula,
revealing the Triangular geometry as the best performing cannula (Table 5).
Table 5 - Cannulae Comparison

4.6

Metric

Circular

Triangular

Occluded

AI

1

2

3

Video

3

1

2

Pressure

3

1

2

Hemolysis

1

1

N/A

Total

8

5

7

DBC’s Use In Vivo

The results of this study are promising but leave many questions to be resolved
upon further testing of the DBC. The practicality of the DBC has been proven for at
least the short term, but further testing and design is needed to bring the idea through to
fruition.

4.6.1 Materials
The RTV11 Silicone used during this experimentation may not be suited for use
in an animal model or ultimately for use in humans. Although the material was sufficient
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for use in short term studies involving blood and biological tissues, the long term
biological effects are unknown. The results of the hemolysis testing suggest that the
material has a negligible effect on hemolysis although the exposure time was only one
hour.
Additionally, RTV11 was used for its flexibility. The cross sections used in this
study were solid and therefore if the same material was used for construction of the
DBC, the tubing would easily collapse under pressures found in the circulatory system.
Also, the material used is a two part compound which is difficult to use in large scale
production.
A suitable material for the DBC would need to be a flexible bio-inert plastic which
is easily molded using injection molding or extrusion forming processes. The DBC
could be made of a number of silicone polymers which are currently used in biodevices.
The flexibility of the DBC is needed to enable the outflow cannula to be easily pushed to
the center of the aortic valve. This is to allow the valve to seal against the cannula as it
did during this study. Additionally, the material should be selected so that it does not
react with the body. Materials which harm the tissue or which cause hemolysis and
thrombogenesis are to be avoided. A bio-reactive material, such as an endothelial cell
scaffolding could be used, but may cause complications with attaching to adjacent
tissues and changing the properties of the material. Ideally, a bio-inert polymer would
enable the cannulae to function as a conduit for blood and have a small impact on the
body’s chemistry. Finally, the material should be chosen so that large scale
manufacture of the DBC is possible by conventional means.
The DBC could be made by injection or extrusion molding techniques common in
production of large quantities of plastic products. There are several technical issues
which would need to be considered for either method. First, is whether the ideal
material for the DBC is suitable for injection or extrusion molding. The next issue is that
the features of the DBC make both injection and extrusion molding difficult. The use of
injection molding would need to employ a removable core in order to leave the final
product hollow. Two ways in which this could be accomplished would be to either use a
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dissolvable insert or to have a mold with a moveable core so that the finished piece
could be removed from the mold. The use of extrusion molding is ideal for the complex
dual lumen shape, but makes the separation and tip design more difficult to
manufacture. These issues would need to be considered along with the material
selection in order to make large scale production feasible.

4.6.2 Interaction with the Heart
One of the unknown factors is how the DBC would behave in a moving heart. It
is unknown if the DBC would stay in place during the heart’s rotation and contraction
each beat. The DBC will need to be able to withstand the twisting and bending applied
by the ventricle without hampering the ventricle’s pumping. Also, the constant cyclic
loading of the DBC could cause degradation of the cannula and this should be
considered for further design modifications of the DBC.
Additionally, for both the occluded valve leaflet and triangular cross sectional
geometries, the sharp corners inherent in those designs may cause inflammation and
other issues when in contact with biological tissues. The radius of these corners needs
to be carefully considered in order to both maintain the intended shape of the cannula
while not causing damage due to the sharpness of the corners.

4.6.3 Thrombogenesis
Due to the DBC’s positioning in the heart, there is the possibility of having areas
where stagnant blood could settle and clot. This is an unwanted outcome of interfering
with the natural flow of blood in the ventricle. The design could be altered to reduce this
effect if it becomes an issue in animal testing and further investigations.
During testing, clotting was noticed on the supporting felt used to secure the
aortic valve in the flow loop. This is despite the fact that anticoagulants were used to
prevent the blood from clotting. It is also important to note that no thrombi were found
on the aortic valve or cannulae during experimentation, although further animal testing
should be conducted to quantify the cannula’s role in thrombogenesis.
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Determining the cannula’s effect on thrombogenesis would require testing in an
animal model for three reasons. First, the blood used was infused with sodium citrate
which is known to inhibit the coagulation of blood. This is a necessary step for using the
blood in the in vitro experiment used in the study in order to allow prolonged storage
and analysis of the blood. If the blood was used without sodium citrate, it is possible
that most the blood would be coagulated before reaching the lab due to physical
agitation of the blood during transport. Second, the mechanism for coagulation is
complex and is regulated by several chemical processes which would be difficult or
impossible to mimic in vivo. Third, long term studies on blood in a bench top flow loop
are not possible due to the inability of preserving the blood. Therefore, the
thrombogenesis of the DBC would be more conclusively determined using an animal
model test.

4.7

Surgical Considerations

Due to the limits of what can be emulated in an in vitro experiment, there are still
some questions about what may affect the cannula’s effectiveness. The development
of new surgical tools and techniques may help bring the DBC to fruition. These
techniques and tools may also differ between the several cross-sectional geometries
tested in this study.
Specifically, the occluded valve leaflet geometry would need a way to secure it to
the wall of the aortic valve without inhibiting the other two leaflets. The occluded valve
leaflet geometry was the most difficult to place in the experimental flow loop and
therefore suggests that it may require additional attachments to the cardiac tissue as
compared to the circular and triangular geometries.
There are several approaches to securing the cannulae surgically. The cannulae
need to be secured to the left ventricular apex as well as inside the ventricle and
possibly to the aorta. The connection to the left ventricular apex could be done by
conventional means or by a yet to be developed method. The conventional cannula
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attachment to the left ventricular apex involves suturing a felt ring to the cardiac tissue
via horizontal mattress stitches.
Some of the additional attachment that the DBC may need to function as
intended would be to anchor the cannula to the interventricular septum and the aorta.
How the DBC would attach to these areas is still being developed.
The purpose of these additional attachment points would be to provide
mechanical support to the interventricular septum and to align the cannula in the aortic
valve. The reason the DBC would provide support to the interventricular septum is to
prevent left ventricular collapse due to VAD support. The VAD can cause negative
gage pressure in the ventricle and this in turn causes the muscle to collapse on itself.
With the ventricle collapsed, the natural output of the ventricle is decreased and the
possibility of occluding the VAD inlet is increased. Additionally, these attachments
could serve to align the DBC in the aortic valve. The attachment at either the
interventricular septum or the aorta could be used for this purpose. Although the DBC
is designed to self center, it may be necessary to further align the cannula through rigid
attachment to the tissue.
Another aspect to consider surgically is where the cannula should outlet to the
aorta. This is important in order to provide sufficient blood flow to all the arteries of the
upper extremities as well as the coronary arteries. If the outlet is too close to the aortic
valve there is a chance that the flexible cannula could be pushed back into the ventricle,
which would result in catastrophic failure of the device. If the outlet extends long past
the aortic valve, the blood flow to the upper extremities and coronaries might be
reduced. Exact length and proper placement of the outflow would vary from patient to
patient, but the outlet of the cannula should extend no further than the aortic arch,
where the first bifurcation of the arteries of the upper extremities is located. This should
provide enough length of cannula downstream of the aortic valve to prevent the cannula
from collapsing into the ventricle while providing sufficient flow to the upper extremities.
Finally, the cannulae would have to be available in several sizes in order to be
successfully used in a wide array of patients. The size of patients’ hearts and aortic
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valves can vary considerably and the DBC needs to be able to accommodate this
variation. The DBC’s size will also depend on the amount of VAD support the patient
needs. The optimal size cannula would be one which compromises making the cannula
small enough as to cause the least disturbance to the aortic valve and making the
interior diameter large enough to reduce the pressure losses across the cannula, and
therefore the work done by the VAD. Conventional cannulae and catheters come in a
few sizes in order to account for patient to patient size variation and VAD loading.
Ideally, the size needed would be selected prior to implantation by correctly sizing the
patient’s heart and aortic valve. During the implantation the surgeon would have the
choice of several sizes in cannula in order to determine which the best fit is for each
patient. This is common practice when implanting conventional cannulae.
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Appendix A: Aortic Valve Dissection
In order to isolate and separate the aortic valve from the rest of the cardiac
tissue, a dissection was performed. The heart was first bisected transversely to divide
the inferior and superior sections of the heart. Take the superior portion of the
remaining heart and cut back the right ventricle along the interventricular septum,
making sure to not cut through the septum. Then cut through the tricuspid valve and
remove the right atrium. You are now left with the pulmonary trunk, aortic root, left
ventricle, and left atrium. Carefully identify the coronary arteries which originate from
the sinus of valsalva at the base of the aortic root. Cut the right coronary, left coronary,
and circumflex arteries 1 cm from the sinus and keep these vessels intact until the valve
is fully separated from the rest of the cardiac tissue. Proceed by carefully bisecting the
mitral valve along the mitral commissures. Close attention must be paid to not injure
the posterior portion of the mitral valve since the aortic valve lies directly behind it. With
mitral valve bisected remove the left atrium. Next, separate the pulmonary trunk and
aortic root by cutting the connective tissue and ligamentum arteriosum. Now cut along
the base of the aortic valve (aortic annulus) and remove the remaining left ventricular
muscle. Also, trim the remaining mitral valve leaflet to the aortic annulus. Now the
aortic valve and aortic root are separated and can be trimmed to size. Cut the aortic
root 5mm superior to the sinotubular junction. Trim the coronaries to about 5mm to
leave enough room to suture the coronaries closed without altering the shape of the
sinus. Rinse the valve with Phosphate Buffered Saline (PBS). The aortic valve is now
separate and ready for further preparations (Massey) (Bell and Bell) (Marieb and
Hoehn) (Aortic Valve Replacement).
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Appendix B: Spectrophotometer Setup
Turn the spectrophotometer on and allow the machine to warm up for a few
minutes. Press the ‘Change Mode’ button until the upper left hand corner of the screen
reads ‘Absorbance’. Press ‘Set nm’ button and adjust the absorbance wavelength (λa) to
540 nm. Pipette 2 mL of Drabkin’s reagent and 1 mL of Distilled water into a plastic
cuvette; this is the ‘0% Hemoglobin’ sample. Pipette 3 mL of Distilled water into a plastic
cuvette; this is the ‘Blank’ sample. Wipe sides with a Kimwipe and stir the mixture until
it has a uniform color. Open the lid on the spectrophotometer and place the ‘Blank’
cuvette in the slot labeled ‘B’ making sure that the arrow on the cuvette aligns with the
notch in the slot. Take the ‘0% Hemoglobin’ sample and place it in the slot labeled ‘1’.
Close the lid on the spectrophotometer. Press the ‘B’ button, and make sure that the
absorbance reading reads 0.000. This ensures that the spectrophotometer is
functioning properly. If the ‘Blank’ sample produces any other reading, consult manual
for troubleshooting. Next press the ‘1’ button and allow 10 seconds for the machine to
take absorbance reading. The value on the screen is the absorbance of the mixture at
540 nm with 0% hemoglobin present in the sample. Press the ‘Set as Blank’ button,
and now the absorbance should read as 0.000. The spectrophotometer is now ready
to read samples from the hemolysis testing.
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Appendix C: Labview User Interfaces and Block Diagrams

Figure 37 - User Interface for Data Acquisition Program
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Figure 38 - Block Diagram for Data Acquisition Program
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Figure 39 - PVS Controller User Interface
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Figure 40 - PVS Controller Block Diagram
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Appendix D: Pressure Transducer Analysis
In section 2.7.1’Pressure’ the analysis of the pressure tap and transducer is
discussed. Following are the derivations for the equations used in that section to
determine the settling time of the system.
In order to use the RLC governing equation, we need to write the electrical
components into their respective fluid analogies.
nd

Equation 11 - RLC Circuit 2 Order Ordinary Differential Equation
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Starting with the definition for electrical inductance, the fluid analogy can be
derived. By drawing between the similarities between the voltage across an electrical
inductor and Newton’s second law of motion, the inductance of the fluid can be derived.
Please note that the bold variables are used to show how the equations relate and
serve to define the fluid inductance, resistance, and capacitance.
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The o term is equivalent to the voltage drop across an inductor and the

volumetric flow rate Q is equivalent to the current, therefore the inductance of the flow is
the following equation.
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Equation 12 - Fluid Inductance

E = 4J
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Similarly, the resistance can be modeled using Ohm’s law and the equation for
pressure drop due to laminar flow in a pipe.
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Again, the pressure drop relates to the voltage and the volumetric flow rate
equates to current.
Equation 13 - Fluid Resistance

GM@98N@7 = 128 Q

K
L#

The capacitance of the system comes solely from the transducer itself. The fluid
capacitance comes from conservation of mass in order to draw similarities from the
equation for voltage across a capacitor.
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The left hand side is the mass flow rate entering the transducer and the right
hand side is the change in total mass of the system. Differentiating reveals the
following equation.
=
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+
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The volume, V, is also a pressure dependent function since the transducer
diaphragm deforms under pressure. Therefore the volumetric change over time can be
defined as follows.

 
=

 
Additionally, since the fluid is incompressible, the density will not change over
time and therefore negating the second term from the right hand side.
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Since A5 is a constant for the transducer defined as maximum displacement

volume over pressure range, we can integrate the expression with the initial condition
P=0.
 =

~
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~

Comparing this equation with the voltage across a capacitor and the fluid
capacitance can be determined. The voltage and change in pressure can be related
along with the volumetric flow rate and current.
=

1
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Equation 14 - Fluid Capacitance
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Using these derivations the pressure tap and transducer system can be modeled.
Although the fluctuation noticed experimentally are pressure fluctuations and the system
model examines volumetric flow rate through the system the two can be correlated.
The importance of modeling the system was to determine the settling time of the
system. When the system comes to a steady state, the flow rate in the pressure taps
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will be zero and the pressure will be constant. Therefore it is reasonable to examine the
settling time of the flow rate even though it is the pressure measurements which is
analyzed in section 2.7.1 (Aerts, Carbonaro and Van den Braembussche, Chapter III Pressure Measurments).
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